GT Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for GT Biopharma (GTBP).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$275Upside to Avg. PT+3773.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Dec 2, 2024	Roth MKM	Jonathan Aschoff	Initiate	Buy	$11

Analyst Ratings News

PRO
Roth MKM Initiates Coverage On GT Biopharma with Buy Rating, Announces Price Target of $11

Roth MKM analyst Jonathan Aschoff initiates coverage on GT Biopharma (NASDAQ:GTBP) with a Buy rating and announces Price Target of $11.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

EF Hutton analyst Tony Butler reiterates GT Biopharma (NASDAQ:GTBP) with a Hold and maintains $2 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

EF Hutton analyst Tony Butler reiterates GT Biopharma (NASDAQ:GTBP) with a Hold and maintains $2 price target.

Benzinga Newsdesk

GT Biopharma Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

GT Biopharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Roth MKM Initiates Coverage On GT Biopharma with Buy Rating, Announces Price Target of $11

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PRO
EF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PRO
EF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

People Also Watch

People Also Watch

GT Biopharma Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

GT Biopharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORoth MKM Initiates Coverage On GT Biopharma with Buy Rating, Announces Price Target of $11

PROHC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PROEF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

PROHC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PROHC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PROEF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

People Also Watch

People Also Watch

PRO
Roth MKM Initiates Coverage On GT Biopharma with Buy Rating, Announces Price Target of $11

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PRO
EF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

PRO
EF Hutton Reiterates Hold on GT Biopharma, Maintains $2 Price Target